Emergent Biosolutions IncEBS
Price$6.37Intrinsic value$8.7838% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $8.78median of 3 methodsbased on filings through 30 Jun 2026
Market Price $6.37Price as of 1 Oct 2026
Margin of Safety +37.9%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: -15.0% (near-term consensus, capped) · years 2–5: 5.2%/yr (balance of the path).0.8% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 64.8%Yr 74.3%Yr 83.9%Yr 93.4%Yr 103.0%
5.2% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)-3.8%
Discount rate (cost of equity) 13.5%
Volatility vs market (adjusted beta)1.91

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetEmergent Biosolutions IncEBSHealth Care
Valuation
P/E—
P/S0.5×
P/B1.0×
EV / Revenue1.0×
EV / EBITDA4.2×
Profitability
Gross margin39.2%
Operating margin6.7%
Net margin-23.0%
FCF margin11.2%
Returns
ROE-51.8%
ROA-15.8%
ROIC—
Growth
Revenue growth (YoY)-26.2%
5-yr fwd EPS growth0.8%
Financial strength
Debt / Equity1.70×
Current ratio5.42×
Altman Z-Score0.9
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.